Provided by Tiger Trade Technology Pte. Ltd.

60 degrees pharmaceuticals, Inc.

1.58
+0.01000.64%
Post-market: 1.580.00000.00%16:04 EDT
Volume:38.44K
Turnover:61.13K
Market Cap:4.17M
PE:-0.13
High:1.63
Open:1.57
Low:1.57
Close:1.57
52wk High:14.68
52wk Low:1.29
Shares:2.64M
Float Shares:2.49M
Volume Ratio:0.67
T/O Rate:1.54%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-11.7300
EPS(LYR):-74.1816
ROE:-200.92%
ROA:-87.17%
PB:-0.68
PE(LYR):-0.02

Loading ...

Company Profile

Company Name:
60 degrees pharmaceuticals, Inc.
Exchange:
NASDAQ
Establishment Date:
2010
Employees:
3
Office Location:
1025 Connecticut Avenue NW,Suite 1000,Washington,District Of Columbia,United States
Zip Code:
20036
Fax:
- -
Introduction:
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for respiratory viruses and dengue. 60 Degrees Pharmaceuticals, Inc. was founded in 2010 and is based in Washington, District Of Columbia.

Directors

Name
Position
Geoffrey Dow
Chief Executive Officer,Director and President
Charles Allen
Independent Director
Cheryl Xu
Independent Director
Paul Field
Independent Director
Stephen Toovey
Independent Director

Shareholders

Name
Position
Geoffrey Dow
Chief Executive Officer,Director and President
Tyrone Miller
Chief Financial Officer
Kristen Landon
Chief Commercial Officer